Barclays’s KORU Medical Systems KRMD Stock Holding History

Barclays’s Portfolio KRMD Stock Details KRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$36.6K	Sell	8,466 -58,976	-87%	-$292K	﹤0.01%	4417
2025 Q4	$392K	Buy	67,442 +5,457	+9%	+$26.1K	﹤0.01%	3982
2025 Q3	$237K	Sell	61,985 -17,134	-22%	-$65.5K	﹤0.01%	4222
2025 Q2	$283K	Buy	79,119 +78,980	+56,820%	+$224K	﹤0.01%	4077
2025 Q1	$353	Sell	139 -2,868	-95%	-$10.7K	﹤0.01%	5101
2024 Q4	$11.6K	Sell	3,007 -485	-14%	-$1.57K	﹤0.01%	4977
2024 Q3	$9.53K	Buy	3,492 +1,157	+50%	+$2.85K	﹤0.01%	4979
2024 Q2	$6.19K	Sell	2,335 -22,692	-91%	-$51.9K	﹤0.01%	4560
2024 Q1	$59.1K	Sell	25,027 -23,064	-48%	-$49.5K	﹤0.01%	4579
2023 Q4	$118K	Buy	+48,091	New	+$115K	﹤0.01%	4597
2021 Q3	–	Sell	-7,083	Closed	-$33K	–	4891
2021 Q2	$33K	Buy	+7,083	New	+$27.8K	﹤0.01%	4323
2021 Q1	–	Sell	-8,703	Closed	-$53K	–	4976
2020 Q4	$53K	Buy	8,703 +7,368	+552%	+$41.2K	﹤0.01%	4378
2020 Q3	$10K	Sell	1,335 -12,048	-90%	-$107K	﹤0.01%	5009
2020 Q2	$120K	Buy	+13,383	New	+$135K	﹤0.01%	4392
2020 Q1	–	Sell	-6	Closed	–	–	6319
2019 Q4	$0	Buy	+6	New	+$29	﹤0.01%	6589

Other funds holding KRMD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

TCM

Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simcoe Capital Spokane, Washington $109M AUM

MIM

Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return

EFMC

Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Barclays's KRMD Position: Q1 2026 in Review

Barclays reduced its KORU Medical Systems (KRMD) stake by 87% in Q1 2026, selling an estimated $292K and leaving 8,466 shares worth $36.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4417.

Barclays first reported a position in KRMD in Q4 2019 and has held it in 15 quarters since. The position peaked at $392K in Q4 2025. 91 funds tracked by Wall St. Rank hold KRMD as of Q1 2026.

Barclays held 8,466 shares of KORU Medical Systems worth $36.6K as of Q1 2026.
Barclays sold 58,976 KORU Medical Systems shares in Q1 2026, an estimated $292K.
KORU Medical Systems made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4417 holding.
Barclays first reported a position in KORU Medical Systems in Q4 2019 and has held it in 15 quarters since.
Barclays's KORU Medical Systems position peaked at $392K in Q4 2025.
91 funds tracked by Wall St. Rank held KORU Medical Systems as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.